Ulinastatin in the treatment of severe acute pancreatitis: A single-center randomized controlled trial

BACKGROUND: Severe acute pancreatitis (AP) is one of the most common diseases of the gastrointestinal tract and carries a significant financial burden with high disability and mortality. There are no effective drugs in the clinical management of severe AP, and there is an absence of evidence-based m...

Descripción completa

Detalles Bibliográficos
Autores principales: Wang, Su-Qin, Jiao, Wei, Zhang, Jing, Zhang, Ju-Fen, Tao, Yun-Na, Jiang, Qing, Yu, Feng
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Baishideng Publishing Group Inc 2023
Materias:
Randomized Controlled Trial
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC10353502/
https://www.ncbi.nlm.nih.gov/pubmed/37469723
http://dx.doi.org/10.12998/wjcc.v11.i19.4601

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC10353502/
https://www.ncbi.nlm.nih.gov/pubmed/37469723
http://dx.doi.org/10.12998/wjcc.v11.i19.4601

Ejemplares similares